DeepScribe Competitive Intelligence & Landscape

DeepScribe (deepscribe.ai) is a pioneering healthcare technology company founded in 2017, headquartered in San Francisco, CA. Their core mission is to unburden clinicians from extensive charting and administrative work, enabling them to focus more on patient care and rediscover the joy in medicine deepscribe.ai/about, deepscribe.ai/careers. The company achieves this through its innovative Ambient OS, an AI-powered platform designed for complex workflows in specialty documentation, coding, and data delivery deepscribe.ai.

DeepScribe offers several key products and services tailored for specialty medicine. Their flagship AI Medical Scribe utilizes advanced speech recognition to accurately document natural clinician-patient conversations, transforming them into customizable, specialty-specific notes deepscribe.ai/solutions/ai-medical-scribe. The SmartPrep solution provides pre-visit intelligence, offering comprehensive patient context for complex care, while AI Coding automates complete and compliant coding with real-time insights and audit-ready documentation deepscribe.ai, deepscribe.ai/solutions. Additionally, the Customization Studio allows the AI to learn and adapt to individual provider styles and workflows, ensuring high adoption rates deepscribe.ai.

DeepScribe primarily targets specialty care providers and value-based care organizations across various medical fields, including cardiology, gastroenterology, neurology, oncology, orthopedics, and urology deepscribe.ai. They are notably a leading ambient system for cancer care, with oncology-specific AI designed for longitudinal care deepscribe.ai. The company emphasizes secure and compliant operations, adhering to HIPAA regulations and acting as a “Business Associate” for healthcare provider customers trust.deepscribe.ai, deepscribe.ai/privacy. DeepScribe has achieved significant milestones, including being the first AI scribe to capture 1 million patient visits, highlighting its widespread adoption and impact in automating medical documentation deepscribe.ai/resources/deepscribe-sets-record-first-ai-scribe-to-capture-1-million-patient-visits.

DeepScribe (deepscribe.ai) offers a comprehensive AI clinical documentation platform designed to streamline administrative tasks for specialty care providers [https://deepscribe.ai/platform]. Their core offerings include an AI Medical Scribe that accurately transforms natural patient-clinician conversations into personalized, specialty-specific notes [https://www.deepscribe.ai/medical-scribe], and SmartPrep (also referred to as AI Pre-charting), which provides pre-visit intelligence by aggregating patient data from EHRs and other sources to prepare clinicians for appointments [https://www.deepscribe.ai/solutions/smartprep]. The platform also features AI Coding to automate complete and compliant coding, reducing administrative burden and ensuring proper reimbursement [https://www.deepscribe.ai/ai-coding], and a Customization Studio that allows the AI to learn and adapt to individual provider workflows and preferences [https://www.deepscribe.ai/solutions/customization-studio].

DeepScribe's product suite extends beyond basic documentation. Their AI Revenue Cycle Management solution integrates medical coding guidance and structured healthcare claims from clinical notes, aiming to surface billable moments, resolve coding gaps, and accelerate reimbursement directly at the point of care [https://www.deepscribe.ai/solutions/ai-coding/revenue-cycle-management]. The company emphasizes its expertise in ambient AI, particularly for complex and longitudinal care settings like oncology, where it helps with comprehensive pre-charting and context-aware notes [https://www.deepscribe.ai/heal-ai].

While DeepScribe highlights a robust and specialized platform, specific pricing plans, tiers, free versus paid features, or recent pricing changes are not explicitly detailed on their public-facing website. The focus of their online content is on demonstrating the value and capabilities of their ambient AI solutions, often encouraging potential clients to

DeepScribe (deepscribe.ai) actively seeks talent to advance its mission of integrating AI with healthcare to alleviate documentation burdens. The company maintains a dedicated "Careers" page, emphasizing its values and commitment to shaping the future of healthcare by bringing humanity back to care [deepscribe.ai/careers]. Their hiring patterns reflect a strategic focus on enhancing their ambient AI operating system, which streamlines complex workflows, from specialty documentation and coding to data delivery [deepscribe.ai].

Recent job postings on DeepScribe's careers page indicate a strong demand for engineering and product development expertise. Open positions include AI Engineer, Software Engineer, Product, and Senior Product Manager, many of which are offered as full-time remote roles within the United States [deepscribe.ai/apply]. This suggests a continued investment in core technology development and product innovation, aligning with their goal of providing sophisticated AI Medical Scribe, SmartPrep, and AI Coding solutions for specialty care [deepscribe.ai].

Beyond technical roles, DeepScribe also seeks a Customer Success Manager, highlighting their commitment to strong client relationships and supporting the adoption of their solutions [deepscribe.ai/apply]. While the company utilizes a robust system that integrates artificial intelligence, machine learning, and remote medical scribes, their approach to medical scribe roles is distinct; these positions often involve working on the backend, monitoring and training AI models to improve documentation automation [deepscribe.ai/resources/medical-scribe-jobs-and-the-shifting-healthcare-landscape].

DeepScribe specifically states that their remote medical scribe positions are "always open" [deepscribe.ai/resources/how-to-get-a-medical-scribe-job], indicating a continuous need for this support as their AI systems evolve.

DeepScribe, founded in 2017, has established itself as a pioneer in ambient AI for healthcare, focusing on alleviating physician burnout and improving documentation efficiency. While specific revenue figures are not publicly disclosed, the company's growth trajectory is evident in its significant impact within the healthcare sector.

DeepScribe is set to document over three million cancer care visits annually, a volume that has doubled since August and quadrupled since January 2025, indicating strong adoption and market penetration, especially in oncology.

DeepScribe has demonstrated strong performance, earning an overall score of 98.8 out of 100 from KLAS Research in an Emerging Company Spotlight Report released in early 2025. This score is notably five-and-a-half points higher than the average for 2024 Best in KLAS Ambient Speech vendors, underscoring its commitment to excellence and provider satisfaction. The company's strategic partnerships, such as with Pearl Health to bring ambient AI documentation to value-based care providers, further solidify its market position and potential for revenue growth through expanded service offerings.

In terms of technological advancements and strategic collaborations, DeepScribe announced in February 2024 that it is working with Amazon Web Services (AWS) to scale its generative AI capabilities in healthcare. This collaboration involves incorporating AWS HealthScribe into its platform, leveraging DeepScribe's purpose-built Large Language Models (LLMs) trained on one of the largest labeled datasets in healthcare. While specific fundraising rounds and valuations are not provided in the given information, these strategic partnerships and high performance scores suggest a robust financial health and a strong foundation for future growth and potential M&A activities within the competitive healthcare AI landscape.

DeepScribe actively participates in and hosts various events, showcasing its innovative ambient AI solutions for healthcare. The company frequently attends major industry conferences, including VIVE 2024 and HIMSS 2024 in Los Angeles, CA, and Orlando, FL, respectively. At these events, DeepScribe (booths #818 and #1561, #4141 at VIVE and HIMSS 2024) DeepScribe and AWS to scale generative AI in healthcare highlights its collaborative efforts with partners like AWS and unveils new features, such as its Real-Time functionality at HIMSS 2024, which generates clinical notes as visits unfold DeepScribe Unveils Real-Time Feature at HIMSS: AI-Generated Clinical Notes as the Visit Unfolds.

DeepScribe also has a strong presence at specialized conferences, particularly in oncology. The company showcased its SmartPrep pre-visit intelligence solution at the Community Oncology Conference in Orlando, FL (booth 308) DeepScribe Introduces SmartPrep, Comprehensive Pre-Visit Intelligence. This demonstrates DeepScribe's commitment to engaging directly with clinicians and practice leaders in the specific fields its AI serves, allowing them to experience the technology firsthand.

In addition to physical conferences, DeepScribe hosts and participates in numerous webinars to educate healthcare professionals on the benefits and applications of ambient AI. One such session, "Improving the Urology Encounter with Ambient AI," featured DeepScribe presenters discussing the company's urology capabilities and the practical implementation of specialty-specific ambient AI Webinar recap: Improving the Urology Encounter with Ambient AI. The company also features its CEO and founder, Matthew Ko, in discussions with industry leaders on its "Beyond the Chart" podcast and in webinars addressing topics like overcoming AI skepticism and the importance of customization in healthcare AI Hidden ROI & Innovation with AI: Unlocking the Future of Cancer Care with Larry Bilbrey, OneOncology.